Oculis (OCSAW) Competitors $8.16 +0.12 (+1.54%) As of 05/30/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock OCSAW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROWShould you be buying Oculis stock or one of its competitors? The main competitors of Oculis include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry. Oculis vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Carmell Celularity CERo Therapeutics Oculis (NASDAQ:OCSAW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends, earnings and community ranking. Does the media refer more to OCSAW or ATNFW? In the previous week, Oculis and Oculis both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.89 beat Oculis' score of 1.87 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Oculis Very Positive 180 Life Sciences Very Positive Is OCSAW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets OculisN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has higher earnings & valuation, OCSAW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOculisN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the MarketBeat Community prefer OCSAW or ATNFW? Oculis and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformOculisN/AN/A180 Life SciencesN/AN/A Summary180 Life Sciences beats Oculis on 1 of the 1 factors compared between the two stocks. Get Oculis News Delivered to You Automatically Sign up to receive the latest news and ratings for OCSAW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OCSAW vs. The Competition Export to ExcelMetricOculisBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$127.85M$5.42B$8.41BDividend YieldN/A3.74%5.28%4.17%P/E RatioN/A3.3227.0519.79Price / SalesN/A4,416.08406.30134.00Price / CashN/A13.1938.2534.64Price / BookN/A33.566.744.50Net IncomeN/A-$91.56M$3.23B$248.30M7 Day Performance1.95%0.57%1.22%0.99%1 Month Performance5.32%3.45%5.99%7.48%1 Year PerformanceN/A168.05%25.78%8.72% Oculis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OCSAWOculisN/A$8.16+1.4%N/AN/A$0.00N/A0.0032Positive NewsGap UpATNFW180 Life SciencesN/A$0.01+2.5%N/A+11.1%$0.00N/A0.007Positive NewsSXTPW60 Degrees PharmaceuticalsN/A$0.06+22.8%N/A-18.1%$0.00$665,452.000.002Gap DownDRTSWAlpha Tau MedicalN/A$0.25+0.0%N/A-10.8%$0.00N/A0.0080Gap UpWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.02+38.3%N/AN/A$0.00N/A0.0059News CoverageShort Interest ↑Gap DownBCTXWBriaCell TherapeuticsN/A$0.10-9.0%N/A-82.2%$0.00N/A0.008Positive NewsShort Interest ↓CDIOWCardio DiagnosticsN/A$0.02flatN/A-66.3%$0.00$19,902.000.007Short Interest ↓Gap DownCTCXWCarmellN/A$0.03+6.8%N/A-71.7%$0.00$32,839.000.0014Gap UpCELUWCelularityN/A$0.08+116.8%N/A+100.5%$0.00$54.22M0.00220Positive NewsGap UpCEROWCERo TherapeuticsN/A$0.01+1.6%N/A-64.0%$0.00N/A0.008Short Interest ↑ Related Companies and Tools Related Companies ATNFW Alternatives SXTPW Alternatives DRTSW Alternatives WENAW Alternatives APLMW Alternatives BCTXW Alternatives CDIOW Alternatives CTCXW Alternatives CELUW Alternatives CEROW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OCSAW) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMidnight trade alert: After-hours spike incoming??? Most traders don’t realize this… But the closing bell means jack $#!&. They hear the bell and they think...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oculis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Oculis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OCSAW Stock Free OCSAW Stock Alerts